1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cytochrome P450

Cytochrome P450

P450

CYPs

Cytochrome p450 comprises a superfamily of heme-thiolate proteins named for the spectral absorbance peak of their carbon-monoxide-bound species at 450 nm. Having been found in every class of organism, including Archaea, the p450 superfamily is believed to have originated from an ancestral gene that existed over 3 billion years ago. Repeated gene duplications have subsequently given rise to one of the largest of multigene families. These enzymes are notable both for the diversity of reactions that they catalyze and the range of chemically dissimilar substrates upon which they act. Cytochrome p450s support the oxidative, peroxidative and reductive metabolism of such endogenous and xenobiotic substrates as environmental pollutants, agrochemicals, plant allelochemicals, steroids, prostaglandins and fatty acids. In humans, Cytochrome p450s are best known for their central role in phase I drug metabolism where they are of critical importance to two of the most significant problems in clinical pharmacology: drug interactions and interindividual variability in drug metabolism.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0852S
    Tebuconazole-d9
    Inhibitor
    Tebuconazole-d9 is the deuterium labeled Tebuconazole. Tebuconazole is an agricultural azole fungicide which can also inhibit CYP51 with IC50s of 0.9 and 1.3 μM for Candida albicans CYP51 (CaCYP51) and truncated Homo sapiens CYP51 (Δ60HsCYP51), respectively.
    Tebuconazole-d<sub>9</sub>
  • HY-17459R
    Clopidogrel (hydrogen sulfate) (Standard)
    Inhibitor
    Clopidogrel (hydrogen sulfate) (Standard) is the analytical standard of Clopidogrel (hydrogen sulfate). This product is intended for research and analytical applications. Clopidogrel hydrogen sulfate is an antiplatelet agent to prevent blood clots. Clopidogrel hydrogen sulfate inhibits CYP2B6 and CYP2C19 with IC50s of 18.2 nM and 524 nM, respectively. Clopidogrel hydrogen sulfate is a potent antithrombotic agent that inhibits ADP-induced platelet aggregation.Clopidogrel hydrogen sulfate also is an orally active P2Y(12) inhibitor.
    Clopidogrel (hydrogen sulfate) (Standard)
  • HY-17508R
    Clarithromycin (Standard)
    Inhibitor
    Clarithromycin (Standard) is the analytical standard of Clarithromycin. This product is intended for research and analytical applications. Clarithromycin has a broad spectrum of antimicrobial activity. Clarithromycin inhibits the CYP3A4-catalyzed triazolam alpha-hydroxylation with the IC50 (Ki) value of 56 (43) μM. Clarithromycin significantly inhibits the HERG potassium current.Clarithromycin affects the autophagic flux by impairing the signaling pathway linking hERG1 and PI3K.
    Clarithromycin (Standard)
  • HY-133091S
    7-Ethoxycoumarin-d5
    7-Ethoxycoumarin-d5 is deuterium labeled 7-Ethoxycoumarin. 7-Ethoxycoumarin is a substrate for cytochrome P450(CYP450) and has been used in the functional characterization of various CYPs[1].
    7-Ethoxycoumarin-d<sub>5</sub>
  • HY-151140
    CYP11B1-IN-2
    Inhibitor
    CYP11B1-IN-2 (compound 7aa) is an orally active, potent and selective CYP11B1 inhibitor, with IC50 values of 9 nM and 25 nM for human CYP11B1 and rat CYP11B1, respectively. CYP11B1-IN-2 can be used for the research of diseases caused by excessive cortisol.
    CYP11B1-IN-2
  • HY-167737
    (-)-Vorozole
    Inhibitor
    (-)-Vorozole is an orally active non-steroidal aromatase inhibitor with potent and selective properties. (-)-Vorozole demonstrates antitumor activity in in vivo experiments. (-)-Vorozole is utilized in the study of breast cancer.
    (-)-Vorozole
  • HY-148595
    Antitumor agent-88
    Inhibitor
    Antitumor agent-88 exhibits potent antimitotic activity and arrests cell in the G2/M phase. Antitumor agent-88 disrupts the microtubule and the cytoskeleton in CYP1A1-expressing breast cancer cells. Antitumor agent-88 is also a competitive inhibitor of CYP1A1 (Ki: 1.4 μM).
    Antitumor agent-88
  • HY-149769
    CP-506
    Substrate
    CP-506 (compound 26) is an anticancer compound and a substrate for nitroreductase and CYP oxidoreductases. CP-506 has anticancer activity.
    CP-506
  • HY-113739
    Desmethylcitalopram hydrochloride
    Inhibitor
    Desmethylcitalopram (DCIT) hydrochloride is the active metabolite of Citalopram (HY-121203). Desmethylcitalopram has antidepressant effects. Desmethylcitalopram also inhibits cytochrome P450-2D6, -2C19 with IC50s of 39.5 and 53.5 μM.
    Desmethylcitalopram hydrochloride
  • HY-116196
    17-HETE
    Activator
    17-HETE is arachidonic acid metabolite through cytochrome P-450 pathways, which consists of 17R-HETE and 17S-HETE enantiomers. 17-HETE serves as allosteric activator of the cytochrome P450 1B1 and inhibitor of ATPase, induces cardic hypertrophy.
    17-HETE
  • HY-E70508
    Human CYP17A1,Low-Reductase
    Human CYP17A1, Low-Reductase, a recombinant CYP17A1, is a member of the CYP enzyme family. CYP17A1 plays a crucial role in human steroid hormone synthesis.
    Human CYP17A1,Low-Reductase
  • HY-137580
    N-Desmethyl Eletriptan
    N-desmethyl Eletriptan is a metabolite of Eletriptan (HY-A0039). It is formed from eletriptan primarily by the cytochrome P450 (CYP) isoform CYP3A4 in human liver microsomes.
    N-Desmethyl Eletriptan
  • HY-E70466
    Human CYP1A2,Low-Reductase
    Human CYP1A2, Low-Reductase, a recombinant CYP1A2, is one of the most important cytochrome P450 (CYP) enzymes in the liver. HCYP1A2 is involved in the metabolism of xenobiotics in the human body.
    Human CYP1A2,Low-Reductase
  • HY-N2071R
    Cedrol (Standard)
    Inhibitor
    Cedrol (Standard) is the analytical standard of Cedrol. This product is intended for research and analytical applications. Cedrol is a potent competitive inhibitor of cytochrome P-450(CYP) enzyme. Cedrol plays an anticancer role by inducing cell cycle arrest and Caspase-dependent apoptosis. Cedrol acts as a neutrophil agonist that can desensitize cells to subsequent stimulation of N-formyl peptides. Cedrol prevents neuropathic pain caused by chronic contractile injury by inhibiting oxidative stress and inflammation. In addition, Cedrol has antibacterial, hair loss prevention and anti-anxiety properties.
    Cedrol (Standard)
  • HY-146177
    CYP3A4 enzyme-IN-1
    Inhibitor
    CYP3A4 enzyme-IN-1 (compound 59) is a potent antibacterial agent, with a MIC of 1 μg/mL for MRSA. CYP3A4 enzyme-IN-1 exhibits low to moderate inhibitory effects on CYP1A2, CYP2E1, CYP2D6, and CYP3A4 enzymes.
    CYP3A4 enzyme-IN-1
  • HY-153989
    SOS1-IN-16
    Inhibitor
    SOS1-IN-16 (Comp 54) is a selective inhibitor of SOS1 with an IC50 of 7.2 nM. SOS1-IN-16 has inhibitory activity of CYP3A4 when using testosterone as a substrate, with an IC50 of 8.9μM. SOS1-IN-16 can be used for cancer research.
    SOS1-IN-16
  • HY-162051
    CYP1B1-IN-6
    Inhibitor
    CYP1B1-IN-6 (compound 19) is a fluorescence molecular probes which inhibits CYP1B1 activity. CYP1B1-IN-6 can identify tumor sites in fluorescence imaging and photoacoustic imaging modes.
    CYP1B1-IN-6
  • HY-172205
    CHL2310
    Inhibitor
    CHL2310 is the inhibitor for CYP46A1 with an IC50 of 0.11 nM, and a Kd of 0.37 nM. CHL2310 can cross blood-brain barrier. CHL2310 can be used as a PET imaging agent, when labeled with radioactive 18F.
    CHL2310
  • HY-E70480
    Human CYP2A13,Low-Reductase
    Human CYP2A13, Low-Reductase, a recombinant CYP2A13, is a member of the CYP enzyme family and is expressed in human extrahepatic tissues.
    Human CYP2A13,Low-Reductase
  • HY-146688
    SYN20028567
    Inhibitor
    SYN20028567 is an aromatase (CYP19) inhibitor with an IC50 of 9.4 nM. SYN20028567 can be used for breast cancer research.
    SYN20028567
Cat. No. Product Name / Synonyms Application Reactivity

CYP1

CYP2

CYP3

CYP4

CYP11

CYP17

Aromatase/CYP19A1

CYP26

CYP51

CYP1A2

CYP2D6

CYP2C9

CYP2C19

CYP3A4

CYP17A1

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Cytochrome P450 Inducers, Degraders, Inhibitors, Activators & Modulators
Product NameCYP1CYP2CYP3CYP4CYP11CYP17Aromatase/CYP19A1CYP26CYP51CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4CYP17A1Purity    
Verapamil  
CYP3
            99.96%
Apigenin 
CYP2
             99.22%
Fenofibrate 
CYP2C19, IC50: 0.2 μM
CYP2B6, IC50: 0.7 μM
CYP2C9, IC50: 9.7 μM
CYP2C8, IC50: 4.8 μM
CYP3A4, IC50: 142.1 μM
            99.97%
Verapamil hydrochloride  
CYP3
            99.98%
Aminoglutethimide      
Aromatase
        98.79%
Letrozole      
Aromatase
        99.95%
Ketoconazole  
CYP3
CYP4
           99.51%
Abiraterone     
CYP17
         99.88%
1-Aminobenzotriazole 
CYP2
CYP3
            99.88%
Abiraterone acetate     
CYP17
         99.96%
Stiripentol 
CYP2
CYP3
            99.99%
Cepharanthine 
CYP2E1, IC50: 25.62 μM
CYP2C9, IC50: 24.57 μM
CYP3A4, IC50: 16.29 μM
            99.91%
Clarithromycin  
CYP3
            99.90%
Gemfibrozil 1-O-β-glucuronide 
CYP2C8, IC50: 4.07 μM
             99.88%
Diosmetin
CYP1
              99.63%
Salvianolic acid C 
CYP2C8, Ki: 4.82 μM
CYP2J2, Ki: 5.75 μM
             99.94%
Oleuropein      
Aromatase
        99.05%
Fomepizole 
CYP2E1
             99.67%
Talarozole       
CYP26
       99.61%
HET0016   
CYP4
           99.69%
Anastrozole      
Aromatase
        99.99%
(S)-Mephenytoin 
CYP2
             99.85%
Galangin
CYP1
              99.96%
Sulfaphenazole 
CYP2C9
             99.85%
Gemfibrozil
CYP1A2, Ki: 82 μM
CYP2C9, Ki: 5.8 μM
CYP2C19, Ki: 24 μM
CYP2C8, Ki: 69 μM
             99.91%
Exemestane      
Aromatase
        99.83%
Cobicistat  
CYP3
            99.77%
Clobetasol propionate  
CYP3A5, IC50: 0.206 μM
CYP3A4, IC50: 15.6 μM
            99.85%
Troleandomycin  
CYP3
            ≥98.0%
Schisandrin A  
CYP3A, IC50: 6.6 μM
            99.89%
Clopidogrel hydrogen sulfate 
CYP2B6, IC50: 18.2 nM
CYP2C19, IC50: 524 nM
             99.43%
Isavuconazole  
CYP3
            99.99%
Bergamottin
CYP1A1, Ki: 10.703 nM
CYP1A1, IC50: 0.192 μM
CYP1A2, IC50: 5.077 μM
CYP2B2, IC50: 4.535 μM
CYP2B1, IC50: 9.495 μM
             99.80%
Gentiopicroside 
CYP2
             99.83%
Ginsenoside C-K 
CYP2C9, IC50: 32 μM
CYP2A6, IC50: 63.6 μM
             99.92%
TMS
CYP1B1, IC50: 6 nM
CYP1A1, IC50: 300 nM
CYP1A2, IC50: 3.1 μM
CYP1B1, Ki: 3 nM
              98.61%
K777  
CYP3
            99.77%
Alpha-Naphthoflavone      
Aromatase
        98.54%
AS1810722  
CYP3A4
            98.14%
Pregnenolone 16α-carbonitrile 
CYP2
CYP3
            98.48%
Olivetol 
CYP2
             99.81%
Ginsenoside Rd
CYP1A2, IC50: 78.4 μM
CYP2D6, IC50: 58 μM
CYP2C9, IC50: 85.1 μM
CYP3A4, IC50: 81.7 μM
            99.88%
Tetrahydrocurcumin 
CYP2C9
CYP3A4
            98.96%
Phillyrin
CYP1
CYP2
             98.99%
Atazanavir  
CYP3
            99.86%
7-Ethoxyresorufin
CYP1
              99.61%
Topiroxostat  
CYP3
            99.06%
Dronedarone  
CYP3
            99.93%
Clomethiazole 
CYP2
             98.65%
Rhapontigenin
CYP1A1, IC50: 400 nM
              99.66%
Curcumenol  
CYP3
            99.98%
BMS-986202 
CYP2C19, IC50: 14 μM
             99.92%
Dihydrokavain           
CYP2C9, IC50: 130.95 μM
CYP2C19, IC50: 10.05 μM
CYP3A4, IC50: 78.59 μM
 99.94%
Galeterone     
CYP17
         99.87%
Atazanavir sulfate  
CYP3
            99.94%
Schisandrol B 
CYP2
CYP3A
            99.99%
Ranitidine hydrochloride 
CYP2
             99.88%
Mephenytoin 
CYP2
             99.96%
Ticlopidine 
CYP2
CYP3
            99.56%
Tebuconazole        
CYP51
      99.66%
CYP3cide  
CYP3A4, EC50: 30 nM
CYP3A5, EC50: 17 μM
CYP3A7, EC50: 71 μM
            99.92%
Endoxifen hydrochloride      
Aromatase
        98.75%
5,7-Dimethoxyflavone  
CYP3A
            99.86%
Chlorzoxazone 
CYP2
             99.84%
Endoxifen      
Aromatase
        99.42%
Bergaptol  
CYP3
            99.44%
Oteseconazole           
CYP2C9, IC50: 99 μM
CYP2C19, IC50: 72 μM
  99.46%
Utreloxastat         
CYP1A2, IC50: > 5.3 μM
     99.69%
Fadrozole hydrochloride      
Aromatase
        99.91%
LKY-047 
CYP2J2, IC50: 1.7 μM
             99.94%
Dihydromethysticin  
CYP3
            99.94%
Cecropin B  
CYP3
            99.00%
(S)-(+)-N-3-Benzylnirvanol            
CYP2C19, Ki: 250 nM
  99.82%
Cedrol 
CYP2
CYP3
            99.76%
APD668 
CYP2C9, Ki: 0.1 μM
             99.73%
Columbamine chloride             
CYP3A4, IC50: 30.6 μM
 98.63%
Obtusifoliol        
CYP51
      99.86%
Fipronil
CYP1
CYP2
CYP3
            98.98%
Casopitant mesylate  
CYP3A4
            99.84%
Fadrozole      
Aromatase
        99.78%
Ginsenoside F1 
CYP2
CYP3A4
            ≥99.0%
Isosilybin  
CYP3
            99.95%
Oxiconazole nitrate  
CYP3A4
            ≥98.0%
AZD7325
CYP1A2
 
CYP3A4
            99.71%
Cephaeline dihydrochloride 
CYP2
             99.84%
Harmalol hydrochloride
CYP1
              99.72%
6',7'-Dihydroxybergamottin  
CYP3A4
            ≥99.0%
Seviteronel     
CYP17
         99.83%
β-​Apo-​8'-​carotenal
CYP1A1
CYP1A2
              
Ranitidine 
CYP2C19
CYP2C9
             ≥99.0%
Liarozole       
CYP26, IC50: 7 μM
       98.83%
Friedelin 
CYP2
CYP3
            ≥99.0%
Flavanone      
Aromatase
        99.84%
Ezutromid
CYP1
              98.10%
Dihydrolanosterol        
CYP51
      99.56%
TP0472993   
CYP4A11, IC50: 140 nM
CYP4F2, IC50: 40 nM
           98.69%
PC945        
CYP51A, IC50: 0.23 μM
CYP51B, IC50: 0.22 μM
      99.27%
AMG-208  
CYP3A4, IC50: 32 μM
            99.86%
Tetrahydropiperine
CYP1A1, IC50: 23 μM
              99.41%
Nicotelline       
CYP26, Ki: ≥300 μM
       99.92%
MS-PPOH 
CYP2
             99.27%
2-Phenyl-2-(1-piperidinyl)propane
CYP1A2, IC50: >300 μM
CYP2B6, IC50: 5.1 μM
CYP2B6, Ki: 5.6 μM
CYP2D6, IC50: 74 μM
CYP2A6, IC50: >300 μM
CYP2C8, IC50: >300 μM
CYP2C9, EC50: >300 μM
CYP2C19, IC50: >300 μM
CYP2E1, IC50: >300 μM
CYP3A, IC50: 200 μM
            99.81%
Dagrocorat 
CYP2D6
CYP3A
            99.90%
(R)-(+)-Aminoglutethimide      
Aromatase
        
Columbamine             
CYP3A4, IC50: 30.6 μM
 99.70%
NN1177 TFA             
CYP3A4
 98.66%
Carbosulfan
CYP1
CYP2
CYP3
            ≥98.0%
Orteronel     
CYP17
         99.70%
Dapaconazole       
CYP26, IC50: 1.4 μM
       99.76%
Quilseconazole        
CYP51
      98.98%
N-Nornuciferine 
CYP2
             99.94%
Linderane 
CYP2
             99.61%
IDO1-IN-19 
CYP2C9, IC50: 8.64 μM
             98.52%
Chrysosplenetin  
CYP3A
            99.68%
Fenofibrate (Standard) 
CYP2B6
CYP2C19
CYP2C8
CYP2C9
CYP3A4
            99.91%
Mefentrifluconazole        
CYP51A, Kd: 0.5 nM
      99.61%
2,6-Dimethylquinoline
CYP1A2, IC50: 3.3 μM
CYP2B6, IC50: 480 μM
             99.95%
ACP-5862 
CYP2C8
CYP3A4
            98.41%
DMU2105
CYP1B1, IC50: 10 nM
CYP1A1, IC50: 742 nM
              99.54%
Nampt-IN-5  
CYP3, IC50: 0.7 nM
            98.02%
Phortress
CYP1
              99.25%
α-​Terpinyl acetate 
CYP2B6, Kd: 5.4  μM
             
ML252
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            99.9%
CYP19A1-IN-2      
Aromatase
        98.88%
D4-abiraterone     
CYP17
         99.75%
CYP1B1-IN-4
CYP1B1, IC50: 0.2 nM
CYP1A1, IC50: 3.98 μM
              99.09%
Liarozole dihydrochloride       
CYP26, IC50: 7 μM
       ≥99.0%
Polygalaxanthone III 
CYP2
             99.76%
ONT-993 
CYP2D6, IC50: 7.9 μM
             99.85%
BI 653048
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            99.84%
BI 689648    
CYP11
          99.20%
DMU2139
CYP1B1, IC50: 9 nM
CYP1A1, IC50: 795 nM
              ≥98.0%
Fomepizole hydrochloride 
CYP2E1
             99.85%
Pradefovir mesylate  
CYP3
            99.89%
Antihistamine-1 
CYP2D6, IC50: 5.4 μM
             99.45%
Exemestane (Standard)      
Aromatase
        99.63%
Abiraterone acetate (Standard)     
CYP17
         99.85%
8-Geranyloxypsoralen  
CYP3
            99.93%
SDZ285428        
CYP51
      98.00%
Dagrocorat hydrochloride 
CYP2D6
CYP3A
            99.85%
CYP4A11/CYP4F2-IN-1   
CYP4A11, IC50: 19 nM
CYP4F2, IC50: 17 nM
           99.82%
SR9186  
CYP3
            98.06%
Seviteronel (R enantiomer)     
CYP17
         98.82%
Letrozole-d4      
Aromatase
        99.82%
Abiraterone decanoate     
CYP17
         99.69%
BMS-819881  
CYP3A4, EC50: 13 μM
            
hCYP3A4 Fluorogenic substrate 1  
CYP3A4, Km: 0.36 μM
            99.27%
MCH-1 antagonist 1  
CYP3A4, IC50: 10 μM
            
1'-Hydroxy bufuralol 
CYP2
             
Eriodictyol chalcone      
Aromatase
        
ε-​Viniferin
CYP1A2, Ki: 5 μM ((EROD))
CYP2B6, Ki: 3 μM ((BROD))
CYP2A6, Ki: 60 μM ((COH))
CYP2E1, IC50: 25 μM ((CHZ))
CYP3A4, Ki: 10 μM ((TST))
CYP4A, IC50: 15 μM ((LwOH))
           ≥98.0%
Gemfibrozil (Standard)
CYP1A2
CYP2C19
CYP2C8
CYP2C9
             99.90%
CYP11B2-IN-1    
CYP11B2, IC50: 2.3 nM
CYP11B1, IC50: 142 nM
          99.83%
Revexepride  
CYP3A4
            99.84%
Clopidogrel-β-D-glucuronide 
CYP2C8
             
1-(Isothiazol-3-yl)ethan-1-one 
CYP2E1
             
Tabimorelin  
CYP3A4
            
Azamulin  
CYP3A, IC50: 0.03-0.24 μM
            
Resorufin methyl ether
CYP1
              99.75%
Chlorzoxazone (Standard) 
CYP2
             99.81%
4,5-Dimethoxycanthin-6-one
CYP1A2, IC50: 1.7 μM
CYP1A2, Ki: 2.6 μM
              98.68%
Dibenzothiophene
CYP1
              99.47%
Vorozole      
Aromatase
        
ODM-204     
CYP17
         
IHMT-PI3Kδ-372 
CYP2C9, IC50: 2.7 μM
             
BMS-986339 
CYP2C8, IC50: 8 μM
CYP2C9, IC50: 13.5 μM
             
Fadrozole hydrochloride hemihydrate      
Aromatase
        
Anastrozole-d12      
Aromatase
        
Endoxifen-d5      
Aromatase
        
CYP3A4-IN-2  
CYP3A4, IC50: 0.055 μM
            
Clarithromycin (Standard)  
CYP3
            
CYP11B1-IN-2
CYP1A2, IC50: >10 μM
CYP2C9, IC50: >10 μM
CYP2C19, IC50: >10 μM
CYP2D6, IC50: >10 μM
CYP2E1, IC50: >10 μM
CYP3A4, IC50: >10 μM
 
CYP11B1, IC50: 9 ± 2 nM (human CYP11B1)
CYP11B1, IC50: 25 nM (rat CYP11B1)
CYP11B2, IC50: 1121 ± 237 nM
          
Antitumor agent-88
CYP1A1, Ki: 1.4 μM
              
17-HETE
CYP1B1
              
SYN20028567      
Aromatase
        
P-gp inhibitor 23             
CYP3A4
 
CYP4Z1-IN-1 
CYP2D6, IC50: >10 000 nM
CYP2C9, IC50: >10 000 nM
CYP3A4, IC50: >10 000 nM
CYP4Z1, IC50: 41.8 ± 1.4 nM
CYP4F11, IC50: 291.3 ± 46 nM
CYP4F12, IC50: 1598.3 ± 5 nM
           
CYP3A4-IN-3  
CYP3A4, IC50: 0.075 μM
            
Diosmetin (Standard)
CYP1
              
CYP1B1-IN-2
CYP1B1, IC50: 0.52 nM
CYP1A1, IC50: 16.7 nM
CYP1A2, IC50: 94.2 nM
              
ERα degrader 9      
Aromatase
        
Ginsenoside C-K (Standard) 
CYP2A6
CYP2C9
             
CYP17-IN-1     
CYP17
         
FGFRs-IN-1         
CYP1A2, IC50: 26.33 μM
CYP2D6, IC50: 9.27 μM
 
CYP2C19, IC50: 11.46 μM
  
CYP1B1-IN-5
CYP1B1, IC50: 4.7 nM
CYP1A1, IC50: 190.7 nM
CYP1A2, IC50: 585.7 nM
              
FGFR-IN-10 
CYP2C9, IC50: 3.33 μM
CYP2C19, IC50: 18.75 μM
CYP2D6, IC50: 4.34 μM
CYP3A4, IC50: 0.69 μM
            
CYP17A1/HDAC6-IN-1              
CYP17A1, IC50: 0.284 μM
hCYP1B1-IN-2
CYP1B1, IC50: 0.040 nM
CYP1A1, IC50: 0.38 nM
              
Ginsenoside Rd (Standard)
CYP1A2
CYP2C9
CYP2D6
CYP3A4
            
Antiproliferative agent-53-d3 
CYP2C19, IC50: 0.77 μM
CYP2C9, IC50: 3.1 μM
CYP2D6, IC50: 17.3 μM
CYP3A4, IC50: 14.6 μM
            
CYP17A1-IN-1     
CYP17, IC50: 26 nM
         
HIV-1 inhibitor-40 
CYP2C9, IC50: 5.16 μM
CYP2C19, IC50: 4.51 μM
             
BChE-IN-33 
CYP2C19
CYP2C9
CYP2D6
             
ASN-001              
CYP17A1
Anticancer agent 78      
Aromatase
        
CYP3A4-IN-1  
CYP3A4, IC50: 0.085 μM
            
CYP51/HDAC-IN-1        
CYP51
      
Exemestane-13C3      
Aromatase
        
Kushenol K  
CYP3A4, Ki: 1.35 μM
            
N-Desmethyl diltiazem hydrochloride  
CYP3A7
            
EGFR-IN-137      
Aromatase, IC50: 4.01 μM
        
PROTAC ERα Degrader-9      
Aromatase, IC50: 4.6 μM
        
CYP1B1-IN-3
CYP1B1, IC50: 6.6 nM
CYP1A1, IC50: 347.3 nM
CYP1A2, IC50: >10000 nM
              
Antitumor agent-87
CYP1A1, Ki: 0.23 μM
              
DL-Acetylshikonin
CYP1A2, IC50: 4.0 μM
CYP2A6, IC50: 3.8 μM
CYP2B6, IC50: 2.0 μM
CYP2C8, IC50: 1.4 μM
CYP2C9, IC50: 3.3 μM
CYP2C19, IC50: 2.5 μM
CYP2D6, IC50: 2.5 μM
CYP2E1, IC50: 2.7 μM
CYP2J2, IC50: 3.3 μM
CYP3A, IC50: 2.3 μM
            
Exemestane-d2      
Aromatase
        
5,7,2',6'-Tetrahydroxyflavone  
CYP3A4, IC50: 7.8 μM
            
7-Ethoxy-4-methylcoumarin
CYP1A1
CYP2B6
CYP2B4
             99.44%
Aromatase-IN-3      
Aromatase, IC50: 54 nM
        
YM511      
Aromatase
        99.73%
BI 653048 phosphate
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            
Exemestane-d3      
Aromatase
        
Apigenin (Standard) 
CYP2
             
CFG920    
CYP11B2
CYP17
         
Nav1.7-IN-8 
CYP2C9, IC50: 0.17 μM
CYP3A4, IC50: 0.077 μM
            
Galangin (Standard)
CYP1
              
JNK-IN-14          
CYP2D6, IC50: 26.7 ± 0.5 nM
  
CYP3A4, IC50: 383.0 ± 1. nM
 
Bucolome 
CYP2
             98.93%
Fenofibrate-d6 
CYP2
CYP3
            99.70%
Oxiconazole  
CYP3A4
            
GlcN-6-P Synthase-IN-1  
CYP3
            
Tetrahydrocurcumin-d6 
CYP2
CYP3
            
Antibacterial agent 132      
Aromatase
        
1,2,3,6,7,8-Hexachlorodibenzofuran
CYP1A1
              
Androsta-1,4,6-triene-3,17-dione      
Aromatase
        
7-Hydroxyflavanone      
Aromatase
        99.59%
Phortress free base
CYP1
              
PROTAC CYP1B1 degrader-2
CYP1B1, DC50: 1 nM
              
hCYP3A4-IN-1  
CYP3A4, IC50: 43.93 nM
            
Monoamine oxidase/Aromatase-IN-1      
Aromatase
        
RO6889678  
CYP3A4
            
CYP51/PD-L1-IN-4        
CYP51, IC50: 0.17 ± 0.0 μM
      
Tabimorelin hemifumarate  
CYP3A4
            
Aromatase-IN-2      
Aromatase
        99.83%
17(S)-HETE
CYP1B1
              
Licopyranocoumarin  
CYP3A4, IC50: 32 μM
            
Methysticin
CYP1A1
              
Thujopsene 
CYP2B6, IC50: 1.3 μM
CYP2C19, IC50: 13.6 μM
CYP2C8, IC50: 29.8 μM
CYP2C9, IC50: 44.9 μM
CYP3A4, IC50: 12.6 μM
            
CYP11B2-IN-2    
CYP11B2, IC50: 0.3 nM
CYP11B1, IC50: 3.8 nM
          
10-Hydroxywarfarin           
CYP2C9, IC50: 1.6 μM
   
Isolimonexic acid      
Aromatase
        
CYP1B1 ligand 3
CYP1B1, IC50: 11.9 nM
CYP1A1, IC50: 278.7 nM
CYP1A2, IC50: 3913.5 nM
              
CYP3A4-IN-4  
CYP3A4
            
Cloperidone           
CYP2C9, IC50: 17.7 μM
   
CYP51/Hsp90-IN-1        
CYP51
      
CYP4Z1-IN-2   
CYP4Z1, Ki: 2.2 μM
           
ML252 hydrochloride
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            
Sorafenib N-oxide             
CYP3A4, Ki: 15 μM
 
Org30958      
Aromatase